Current Opinion in Hematology volume 19, issue 2, P65-70 2012 DOI: 10.1097/moh.0b013e32834ff58a View full text
|
|
Share
Raphael Itzykson, Pierre Fenaux

Abstract: The indication and practical use of HMAs in MDS so far remain those of phase III registration studies, but will hopefully be modified with future results of ongoing clinical and translational research.